Stockfacts
Use CasesDocsPricing
Log inSign up free
OverviewFinancialsTrendsTranscriptsOptionsShortsInstitutionsInsidersCorporate ActionsSEC Filings
Stockfacts

EOD US-equity data for investors and AI agents

Data is end-of-day, not real-time, and not investment advice

Use CasesDashboard

DNTH

Dianthus Therapeutics, Inc. /DE/

CIK 0001690585 · Nasdaq

NasdaqHealth CarePharmaceutical Preparations
$111.10
↑ 1.59 (1.45%)
as of Aug 21, 2026
End-of-day close, not real-time intraday
Live price (Google Finance) ↗
Overall read: BullishOverall score · based on 4/4 lenses
FundamentalsOwnershipTechnicalsOptions

Bullish: Ownership, Technicals, Options

Key stats

Market Cap
$6.21B
P/E Ratio
-32.32
EPS
-4.20
Dividend Yield
Not covered
52W Position
93%
Beta
0.91

Valuation multiples

Fwd P/E
Not covered
PEG
Not covered
P/B
5.30
P/S
336.14
EV/Revenue
330.16
ROE
-16.4%
Valuation data covers 8,711/9,697 US-listed stocks (89.8%).

Price · 1Y

251 trading days

End-of-day close, not real-time intraday

52-Week RangePosition 93%
$22.76$117.88

Latest Financials

2025-12-31 FY
Revenue
$2.04M
Net Income
-$162.34M
Total Assets
$530.92M
Free Cash Flow
-$129.27M

Recent news